U.S. regulators on Tuesday authorized a COVID-19 booster shot for healthy 5- to 11-year-olds, hoping an extra vaccine dose will enhance their protection as infections once again creep upward.
Everyone 12 and older already was supposed to get one booster dose for the best protection against the newest coronavirus variants — and some people, including those 50 and older, can choose a second booster.
The Food and Drug Administration’s authorization now opens a third shot of Pfizer’s vaccine to elementary-age kids, too — at least five months after their last dose.
There is one more hurdle: The Centers for Disease Control and Prevention must decide whether to formally recommend the booster for this age group. The CDC’s scientific advisers are scheduled to meet on Thursday.
Pfizer and its partner BioNTech make the only COVID-19 vaccine available for children of any age i n the U.S. Those ages 5 to 11